Innovation Summit - 2025

2025 Featured Speakers

Patrick Carroll MED ’84 | Chief Medical Officer, HIMS-HERS

Bio coming soon.

Steven Leach, MD | Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer; Director, Dartmouth Cancer Center; Incoming Interim Dean, the Geisel School of Medicine at Dartmouth

Image

Steven D. Leach, MD, a surgical oncologist, and pancreatic cancer researcher, leads Dartmouth Cancer Center, a joint enterprise of the Geisel School of Medicine at Dartmouth and Dartmouth Health. Leach serves as a professor in multiple departments within Geisel and Dartmouth’s Guarini School of Graduate and Advanced Studies. On September 15, Dr. Leach will begin a new role as Geisel’s interim dean.

Recruited from Memorial Sloan Kettering in 2017, Leach previously held the David M. Rubenstein Chair and was the inaugural director of the Rubenstein Center for Pancreatic Research. In that role, Leach directed a large research team focused on the biology, genetics, and treatment of pancreatic cancer. Prior to that, Leach spent 14 years at Johns Hopkins University, where he served as the Paul K. Neumann Professor in Pancreatic Cancer, chief of the Division of Surgical Oncology, and vice-chair of academic affairs in the Department of Surgery. 

In addition to his clinical and administrative roles, Leach continues to lead a highly productive research lab focused on pancreatic cancer biology. Among his many scientific contributions and professional honors, Leach was named a Fellow of the American Academy for the Advancement of Science in 2018 and in 2023 was elected to the National Academy of Medicine. Leach has also served as chair of the Pancreatic Cancer Action Network’s Scientific and Medical Advisory Board and as a member of the Princeton University Board of Trustees. 

A graduate of Princeton University, Leach earned his medical degree at Emory University, followed by a residency at Yale University. There, he served as chief resident in general surgery and completed a research fellowship in surgery and cell biology. Leach completed an additional fellowship, in surgical oncology, at MD Anderson Cancer Center. 

Lisa Marsch, PhD | Andrew G. Wallace Professor, Founding Director, Center for Technology and Behavioral Health at Dartmouth

Image

Dr. Lisa A. Marsch is the Founding Director of the Dartmouth Center for Technology and Behavioral Health, a designated “Center of Excellence” supported by the National Institute on Drug Abuse at the National Institutes of Health.

She is also the Director of the Northeast Node of the National Drug Abuse Clinical Trials Network based out of Dartmouth and the Andrew G. Wallace Professor within the Departments of Psychiatry and Biomedical Data Science at the Geisel School of Medicine at Dartmouth College.

The Dartmouth Center for Technology and Behavioral Health (CTBH) is a national interdisciplinary Center housed at Dartmouth and includes affiliates within the Geisel School of Medicine, the College of Arts and Sciences, The Thayer School of Engineering, and the Dartmouth Institute for Health Policy and Clinical Practice. CTBH also includes interdisciplinary partners across the U.S. and internationally.

This Center uses science to inform the development, evaluation, and sustainable implementation of digital health tools (that leverage mobile, sensing and data analytics approaches) for behavior change targeting a wide array of populations and health behaviors. These tools are designed to deliver engaging and effective health monitoring and health behavior interventions and to collectively lead to transformations in the delivery of science-based health care.

In addition to directing this national Center, Dr. Marsch has been Principal Investigator on 40 grants, largely from the National Institutes of Health. She has led the development, evaluation and implementation of digital therapeutics for addiction treatment, HIV prevention, mental health, chronic pain management, substance abuse prevention, smoking cessation, and binge eating disorder. Her work in technology and addiction treatment has been particularly pioneering, as she is widely recognized as having led the development of one of the most widely tested and evidence-based mobile intervention for addiction treatment.

She additionally maintains a priority focus on mentoring investigators, including junior faculty as well as students and post-doctoral fellows.

Dr. Marsch publishes extensively and is a regular keynote speaker at national and international scientific meetings (including invited presentations at the White House, U.S. Congress, the World Bank, and for the US Surgeon General). She has served as a consultant to the Department of Mental Health and Substance Abuse at the World Health Organization and on the National Advisory Council to the National Institute on Drug Abuse at the National Institutes of Health. She serves on the Scientific Advisory Board of the Campus for Research Excellence and Technological Enterprise (CREATE) in Singapore.

Tom Osborne, MED ’01 | Chief Medical Officer, Microsoft Federal

Bio coming soon.

Uciane Scarlett, PhD ’11 | Life Sciences Venture Firm Principal and Investor

Bio coming soon.